PIH or PIE? The Difference Between Acne Marks and the Barrier Approach
Key Findings
- PIH marks appear brown-to-gray on dermoscopy; dermal PIH is far more treatment-resistant than epidermal PIH and can persist for months.
- In PIE, damaged perifollicular capillaries stay dilated; oxyhemoglobin's absorbance at 540–577 nm wavelength is what produces the visible red color.
- Clinical research shows post-acne PIH risk can rise by up to 40% in people with compromised barrier integrity; ceramide deficiency directly drives this risk by prolonging inflammation.
- The CIRÈLL Biomimetic TriBarrier System supports the ceramide, cholesterol, and free fatty acid balance at physiological ratios, aiming to prevent post-inflammatory discoloration from becoming chronic.
- Sunscreen use reduces PIH darkening by more than 60%, while our niacinamide content shows that 5% niacinamide meaningfully lightens PIH marks within 4 weeks.
Have a clinical question?
Consult directly with our pharmacist.
Consult via WhatsAppPharm. Mine Ekber
PIH and PIE: Two Fundamentally Different Acne-Mark Mechanisms
The discoloration left behind after an acne breakout heals isn't the same for everyone — the color, depth, and persistence of the mark on your skin directly depend on which mechanism is at work.
What Is Post-Inflammatory Hyperpigmentation (PIH)?
PIH is a melanin-accumulation process triggered by overstimulation of melanocytes during inflammation. As an acne lesion forms, released pro-inflammatory cytokines — chiefly IL-1α, TNF-α, and prostaglandins — generate melanocyte-stimulating-hormone-like signals that push melanocytes into excess melanin synthesis. This melanin is transferred to keratinocytes and accumulates in the epidermal layers as yellow-brown, dark brown, or gray discoloration. In more severe lesions, melanin crosses the basal membrane and drops into the dermis; this "dermal PIH" is the most stubborn form and can persist for years.
What Is Post-Inflammatory Erythema (PIE)?
PIE is a vascular phenomenon unrelated to melanin. During acne inflammation, perifollicular capillaries are damaged and become dilated. Even once inflammation resolves, these capillaries fail to return to their normal diameter; the oxyhemoglobin within them appears as a pink-red color at the surface. Pressing on PIE (the diascopy test) causes it to temporarily blanch — the most practical way to distinguish it from PIH. PIE is observed more often in fair and medium skin tones, while PIH tends to dominate in darker skin tones.
Quick Comparison Table
| Feature | PIH | PIE |
|---|---|---|
| Color | Brown, dark brown, gray-black | Pink, red, purple-red |
| Mechanism | Excess melanin accumulation | Dilated capillaries / vascular damage |
| Diascopy test | Doesn't blanch | Temporarily blanches under pressure |
| Depth | Epidermal + dermal (in deep form) | Superficial dermis |
| More common in | Fitzpatrick III–VI | Fitzpatrick I–III |
| Time to fade on its own | 3 months – 2+ years | 3–12 months |
| Core active approach | Melanin synthesis inhibitors | Vascular repair / anti-inflammatory |
The Skin Barrier's Central Role in PIH and PIE
Many people think of PIH and PIE as a purely localized skin issue — but barrier integrity is actually a major variable that affects both the severity and duration of each condition.
A Compromised Barrier Prolongs Inflammation
The skin barrier — chiefly the stratum corneum's lipid layer — is the first line of defense against external pathogens and irritants. When the physiological 1:1:1 ratio of ceramides, cholesterol, and free fatty acids is disrupted, transepidermal water loss (TEWL) rises, epidermal pH increases, and cytokine activation becomes chronic. This chronic low-grade inflammation continuously stimulates melanocytes, deepening PIH, while preventing capillary healing, making PIE persistent.
Ceramide Deficiency Is a Direct Risk Factor
Actives commonly used in acne treatment — benzoyl peroxide, retinoids, and AHA/BHA — can significantly deplete ceramide reserves. Exfoliating actives like retinoids and AHA/BHA speed up cell turnover, which can also shorten the time available for epidermal lipid synthesis. Given ceramide's role in the skin barrier, this makes clear why active barrier support is essential during treatment, not optional. Without ceramide supplementation, acne treatment can paradoxically increase PIH and PIE risk.
Microbiome Imbalance Feeds Chronic Inflammation
Dysbiosis that develops following a Cutibacterium acnes infection delays barrier repair and keeps inflammatory signaling active. A healthy skin microbiome hosts ceramide-producing bacteria that support the resynthesis of barrier lipids; when this balance is disrupted, the risk of PIH becoming chronic increases.
Evidence-Based Active Ingredients and Percentages for PIH
In treating PIH, compounds that target melanin synthesis and block melanosome-to-keratinocyte transfer stand out as first-line options.
Niacinamide (4–10%)
Niacinamide blocks melanin accumulation by inhibiting protease-activated receptor-2 (PAR-2), which transports melanosomes into keratinocytes. In a clinical trial, daily application of a 5% niacinamide moisturizer for 4 weeks significantly reduced hyperpigmentation compared with vehicle.[2] Both safe and well tolerated, niacinamide also supports barrier repair, making it an ideal dual-purpose choice for PIH.
Alpha Arbutin (1–2%) and Kojic Acid (1–4%)
Both compounds inhibit tyrosinase, the key enzyme in melanin synthesis. Alpha arbutin, though a hydroquinone derivative, has a much lower cytotoxicity profile. Kojic acid is a natural compound derived from fungal fermentation, but it carries a risk of contact dermatitis above 2% concentration, so careful dose titration is needed for people with compromised barrier integrity.
Tranexamic Acid (2–5%)
Tranexamic acid reduces melanin synthesis by blocking the plasminogen activator pathway involved in keratinocyte-melanocyte interaction. Topical 5% concentration applied over 12 weeks has shown a meaningful lightening effect in clinical studies. It's worth noting that its use requires physician approval given pregnancy-safety considerations.
AHA and BHA: Clearing Melanin Through Renewal
Glycolic acid (5–10%) and mandelic acid (10%) speed up the shedding of melanin-containing corneocytes, clearing epidermal PIH more quickly. Salicylic acid (0.5–2%) both reduces new acne formation through its comedolytic effect and helps existing melanin deposits clear from the surface more easily. It's worth keeping in mind that high concentrations and frequent use of AHA/BHA can disrupt barrier integrity.
Retinoids: Speeding Up Cell Turnover
Retinol and tretinoin speed up cell renewal, supporting both epidermal PIH clearance and acne control. However, since they carry a risk of barrier irritation and paradoxical inflammation in the early stages, it's recommended to start at a low concentration (retinol 0.025–0.05%) and increase gradually. Our dedicated retinol and skin barrier guide covers the detailed application protocol.
Evidence-Based Active Ingredients and Approaches for PIE
Because PIE is a vascular issue rather than a melanin one, it calls for an entirely different family of compounds — melanin-targeted ingredients show no meaningful effect on PIE.
Azelaic Acid (10–20%)
Azelaic acid works through a dual mechanism in PIE, combining anti-inflammatory and anti-angiogenic properties: it suppresses the inflammatory signaling surrounding dilated capillaries while its antimicrobial effect helps prevent new acne formation. Used at 10% over the counter or 15–20% by prescription.
Centella Asiatica / Madecassoside
Madecassoside and asiaticoside stimulate collagen synthesis, contributing to the rebuilding of the damaged perifollicular matrix, and reduce vascular permeability. Through this anti-inflammatory mechanism, they meaningfully reduce PIE redness within weeks.
Panthenol (Pro-Vitamin B5, 1–5%)
Once absorbed into the skin, panthenol converts to pantothenic acid, supporting cell renewal and endothelial repair. Its anti-inflammatory, soothing properties reduce PIE's redness and sensitivity. Given its role in the skin barrier, panthenol is a top choice for both PIE and general barrier support.
Ectoin: Stress Protection and Anti-Inflammatory Action
Ectoin is a stress-protective compound derived from microorganisms adapted to extreme conditions. By reducing pro-inflammatory cytokine activation, it prevents vascular damage from becoming chronic and shortens PIE's healing timeline.
Niacinamide + Zinc Combination
Niacinamide reduces pigmentation by suppressing melanosome transfer; combining it with zinc can be considered a supportive protocol in mixed presentations where PIH and PIE coexist.[2]
A Holistic Approach to PIH/PIE Management With the CIRÈLL Biomimetic TriBarrier System
Active ingredients can be effective against PIH and PIE, but applied without barrier support, their effectiveness drops and the risk of additional irritation rises. CIRÈLL's core thesis is this: active targeting and barrier repair should run in parallel, not in sequence.
What Is the Biomimetic TriBarrier System?
The CIRÈLL Biomimetic TriBarrier System is designed to rebuild the stratum corneum's natural lipid architecture. Ceramides (a blend including NP, AP, and EOS forms), cholesterol, and linoleic-acid-rich free fatty acids are combined at a 1:1:1 ratio to create the physiological equivalent of the lamellar lipid structure. This structure:
- Reduces transepidermal water loss, preventing post-inflammatory dryness,
- Restores epidermal pH to its acidic protective zone, calming melanocyte activation,
- Optimizes the effectiveness of active molecules (niacinamide, azelaic acid, madecassoside) by improving their transepidermal penetration.
Application Protocol: A Step-by-Step PIH/PIE Routine
Choose a sulfate-free, pH-balanced cleanser. Harsh cleansers deplete ceramide reserves, raising TEWL and triggering inflammatory signaling.
For PIH: niacinamide 5–10%, tranexamic acid 2–5%, alpha arbutin 1–2%. For PIE: azelaic acid 10%, centella asiaticoside, ectoin. A niacinamide + madecassoside combination can be a good choice for mixed presentations.
Apply a ceramide-containing barrier moisturizer over your active serum. This step helps actives stay in the skin and reduces irritation risk.
For PIH, sun protection isn't an addition — it's a required therapeutic component. UV rays directly activate melanocytes, deepening existing PIH and accelerating new mark formation. Mineral filters (zinc oxide, titanium dioxide) tend to be better tolerated on sensitive and barrier-compromised skin.
AHA (5–10% glycolic or mandelic acid) or BHA (0.5–1% salicylic acid) can be applied 1–2 times a week. If barrier sensitivity is high, pause exfoliation temporarily and prioritize barrier repair.
Prioritizing Treatment When PIH and PIE Occur Together
Most people dealing with post-acne marks have both PIH and PIE present at the same time. The recommended strategy for this mixed presentation: focus on barrier repair and anti-inflammatory support for the first 4–6 weeks (azelaic acid + centella + ceramide moisturizer + SPF), then add melanin-targeted actives (niacinamide + tranexamic acid). Applying melanin-targeted actives while the barrier is still compromised invites new irritation-driven inflammation, and therefore new PIH. This sequencing matters especially for sensitive and reactive skin types.
Common Mistakes to Avoid
Mistakes made while managing PIH and PIE can worsen outcomes rather than improve them; here are the most common pitfalls.
Picking at Blemishes and Mechanical Damage
Manually squeezing an acne lesion or subjecting it to mechanical irritation directly deepens dermal pigmentation and worsens the capillary damage that's critical to PIE. Where post-inflammatory changes are concerned, never touching the lesion at all is the single most effective preventive measure.
Applying Too Many Actives at Once
Combining niacinamide + AHA + retinol + benzoyl peroxide without barrier support creates a cumulative irritation load. This reactivates the inflammatory cascade, raising the risk of both PIH and PIE. Choosing "fewer, but right" actives always outperforms a "more, but mismatched" strategy.
Skipping Sunscreen
Sunlight is PIH's biggest enemy. UV-A and UV-B radiation directly activate melanocytes; a single week of sun exposure can undo months of treatment progress. Using a broad-spectrum SPF 50 delivers a far stronger clinical result than any brightening active on its own.
Exfoliating While the Barrier Is Compromised
Applying acid peels or physical exfoliation while the skin barrier is weakened creates micro-channels, raising both irritation and the risk of PIH becoming chronic. Our comprehensive guide on how to tell whether your skin barrier is healthy can help you assess whether you're ready for exfoliation.
Managing PIH/PIE by Skin Type and Demographic Factors
PIH and PIE risk isn't universal — it varies meaningfully by skin tone, hormonal status, geography, and age.
Fitzpatrick III–VI Darker Skin Tones: A PIH-Focused Protocol
Melanocyte activity is naturally higher in darker skin tones, so an acne lesion of the same severity can leave much more prominent PIH. In this group, potent melanin inhibitors like hydroquinone should only be used under dermatologist supervision; first-line options should be tranexamic acid, alpha arbutin, and niacinamide. Peel acid concentrations should be kept low, and barrier support should never be skipped.
Fitzpatrick I–II Fair Skin Tones: A PIE-Focused Protocol
Vascular reactivity is more pronounced in fair skin, and PIE redness can remain visible even under makeup for several months. In this group, vascular-focused actives (azelaic acid, centella, ectoin) and collagen-supporting compounds take priority. Heat and sun exposure directly worsen PIE, so SPF use is recommended even during indoor activities.
Hormonal Acne and PIH: Women Ages 25–40
Hormonal fluctuations (menstrual cycle, PCOS, pregnancy) significantly raise PIH risk by increasing melanocyte-stimulating hormone levels. Hydroquinone and tretinoin are contraindicated during pregnancy; tranexamic acid, azelaic acid, and niacinamide are more suitable options for this period — though physician consultation remains essential.
Adolescents and Young Adults: The Acne + PIH Cycle
This group often has to manage PIH/PIE while active acne is still ongoing. Melanin-targeted treatment becomes a repeating cycle without acne control first. Acne control should be established first, followed by a PIH/PIE protocol. A barrier-protective baseline routine is the foundation of this transition.
Seasonal and Environmental Factors
PIH darkening in summer, driven by increased UV intensity, is a nearly universal phenomenon. In winter, heating systems lower ambient humidity, raising barrier TEWL and setting the stage for chronic low-grade inflammation. Increasing sun protection during the spring-to-summer transition and intensifying barrier moisturizer during the fall-to-winter transition are the core strategies for seasonal PIH/PIE management.
What Do These Signs Mean for You?
Understanding which mechanism is behind the changes you're seeing on your skin after acne is the first step to choosing the right products and protocol.
Flat, brown or dark brown marks left after an acne lesion heals point to epidermal PIH. Melanin has accumulated in the keratinocyte layers; it can be managed with melanin synthesis inhibitors and AHAs. Color doesn't change when you press on it.
Pink-red flatness left after acne heals suggests PIE. If it temporarily blanches under finger pressure (diascopy positive), the diagnosis is nearly certain. Since dilated capillaries are the cause, vascular-targeted actives are needed.
Gray, blue-gray, or dark gray tones suggest dermal PIH — melanin has crossed the basal membrane and dropped into the dermis. This is the most resistant form of PIH, and its response to topical treatment is much slower than epidermal PIH; a dermatologist evaluation is recommended.
A sensation of heat, burning, or excessive sensitivity in active PIH or PIE areas signals ongoing barrier damage. When this symptom is present, reducing active-ingredient load and switching to a barrier repair protocol is the priority — otherwise inflammation becomes chronic and PIH/PIE worsens.
Conclusion
PIH and PIE are two distinct post-acne mechanisms, and managing them calls for different active ingredients. PIH calls for melanin synthesis inhibition; PIE calls for vascular repair and anti-inflammatory support; and mixed presentations call for building a barrier and anti-inflammatory foundation first, then adding melanin-targeted actives. In both cases, sun protection and supporting barrier integrity are unquestionably the two most critical foundational steps.
The CIRÈLL Biomimetic TriBarrier System is built on the principle of supporting active ingredients and barrier repair simultaneously. By restoring the balance of ceramides, cholesterol, and physiological fatty acids, it both increases the effectiveness of active treatment and helps prevent new inflammatory cycles from starting. In post-acne skin management, the barrier isn't a background consideration — it's a primary therapeutic target.
Frequently Asked Questions
What's the core difference between PIH and PIE?
PIH (post-inflammatory hyperpigmentation) refers to flat, brown, dark brown, or gray discoloration caused by melanocytes overproducing melanin after acne. PIE (post-inflammatory erythema) is a pink-red discoloration caused by damaged capillaries that fail to heal and stay dilated during acne inflammation. The practical distinguishing test: if pressing the mark with a finger causes temporary blanching (diascopy positive), it's likely PIE; if it doesn't blanch, it's likely PIH. This mechanism difference completely changes the treatment approach — PIH requires melanin-targeted actives, while PIE requires vascular repair and anti-inflammatory compounds.
How does PIH form? What's the mechanism?
During the inflammation caused by an acne lesion, pro-inflammatory cytokines like IL-1α, TNF-α, and prostaglandins are released. These cytokines activate melanocyte-stimulating-hormone-like signaling pathways, pushing melanocytes into excess melanin synthesis. The melanin produced is distributed to surrounding keratinocytes via the PAR-2 transport protein and accumulates in the epidermal layers — this is epidermal PIH. In more severe inflammation, melanin crosses the basal membrane and drops into the dermis, forming dermal PIH; this form is far more resistant and can persist for years.
How does PIE form? What's the mechanism?
During acne inflammation, the capillaries surrounding the follicle are damaged and become dilated. Under normal conditions, these vessels return to their original diameter once inflammation resolves — but in PIE, this normalization doesn't happen. The oxyhemoglobin in the still-dilated capillaries absorbs light at 540–577 nm, appearing as a pink-red color. This is a purely vascular phenomenon with no connection to melanin. That's why melanin-targeted actives like niacinamide show no meaningful effect on PIE; compounds that support vascular repair — azelaic acid, centella asiaticoside, and ectoin — should be preferred instead.
Which active ingredients and percentages are used for PIH?
First-line actives for managing PIH include: niacinamide 4–10% (inhibits melanosome transfer, meaningful effect at 4 weeks), tranexamic acid 2–5% (blocks the plasminogen activator pathway), alpha arbutin 1–2% (tyrosinase inhibitor, low cytotoxicity), kojic acid 1–2% (natural tyrosinase inhibitor, dermatitis risk above 2%), glycolic acid 5–10% (accelerates cell turnover, clears epidermal melanin), mandelic acid 10% (a gentle AHA well suited to fair skin), and retinol at a 0.025–0.05% starting dose (speeds up cell renewal). All of these actives must be combined with sunscreen, or their effect is lost.
Which active ingredients and percentages are used for PIE?
Vascular- and anti-inflammatory-focused actives lead the way for managing PIE: azelaic acid 10% (over the counter, anti-inflammatory + anti-angiogenic), azelaic acid 15–20% (prescription, stronger effect), Centella asiatica extracts containing madecassoside/asiaticoside (collagen synthesis + reduced vascular permeability), panthenol 1–5% (endothelial repair, anti-inflammatory), ectoin 1–2% (cytokine inhibition, stress protection), and niacinamide 4–5% (mild effect on both the vascular and melanin components). AHA and retinol have no direct effect on PIE — and can actually worsen it by causing irritation.
Which actives should be used if PIH and PIE occur together?
In a mixed PIH+PIE presentation, the most sensible protocol is to build an anti-inflammatory and barrier foundation first, then add melanin-targeted actives. For the first 4–6 weeks: azelaic acid 10% + centella asiatica + a ceramide-containing barrier moisturizer + SPF 50. Once the barrier has stabilized, niacinamide 5–10% and tranexamic acid 2–5% are added. Trying too many actives at once creates an irritation load and can trigger a new inflammatory cascade, deepening both PIH and PIE. Because the niacinamide + azelaic acid combination shows synergistic effects on both presentations, it's an ideal starting pair for mixed cases.
How is barrier health related to PIH and PIE?
When the skin barrier is compromised, transepidermal water loss (TEWL) rises, epidermal pH increases, and cytokine activation becomes chronic. This chronic inflammatory environment continuously stimulates melanocytes, deepening PIH, and delays capillary repair, allowing PIE to persist. Research shows post-acne PIH risk can rise by up to 40% in people with compromised barrier integrity. Ceramide deficiency is common, particularly due to the retinoids and benzoyl peroxide frequently used in acne treatment — which is why barrier support is an inseparable part of active treatment.
Is PIH risk higher in people with darker skin tones?
Yes. In Fitzpatrick III–VI skin tones, melanocyte count is similar to fairer skin, but melanocyte activity and melanin transfer capacity are much higher. As a result, an acne lesion of the same severity leaves much more prominent, longer-lasting PIH. Dermal PIH risk is also higher in this group. Potent melanin inhibitors like hydroquinone should only be used under dermatologist supervision; tranexamic acid, alpha arbutin, niacinamide, and azelaic acid are safe, effective first-line options. AHA peel concentrations should be kept low, and sun protection is unquestionably the single most critical measure.
Should PIH/PIE management differ for younger people (ages 15–25)?
The main challenge for adolescents and young adults is needing to manage PIH/PIE while active acne is still ongoing. This age group faces a cyclical risk: acne → PIH/PIE → active treatment → irritation → new acne. Breaking this cycle requires establishing acne control first (appropriate acne care and, if needed, dermatologist-supervised treatment), then moving to a PIH/PIE protocol. Retinoic acid derivatives are valuable in this age group since they work on both acne and PIH at once, but should be titrated slowly due to initial irritation. Building sunscreen habits at this age is especially important.
Why does PIH darken more in summer?
UV-A and UV-B radiation directly activates melanocytes, speeding up melanin synthesis. Sunlight intensity increases in summer, so existing PIH marks darken and new marks form more quickly. Heat also worsens PIE's redness by causing capillary dilation. Using broad-spectrum SPF 50 throughout summer is essential; brightening active serums shouldn't be applied in the morning — move them to your nighttime routine instead. During peak sun hours (10am–4pm), physical protection (a hat, face covering) complements barrier protection.
Should you choose expensive products for PIH, or do low-cost ingredients work?
Clinical effectiveness for PIH management is tied to active concentration and formulation quality, not price. An affordable serum containing 5% niacinamide is far more effective than an expensive serum containing only 1% niacinamide. The most critical "product" — broad-spectrum sunscreen — is non-negotiable for your routine regardless of cost. Because a ceramide barrier moisturizer improves the penetration and effectiveness of active ingredients, an inexpensive but correctly formulated one offers strong return on investment. Evidence-backed actives (niacinamide, azelaic acid, tranexamic acid) are available over the counter at reasonable prices; a targeted selection is more valuable than an expensive multi-ingredient blend.
Do PIH/PIE ingredients have side effects?
Each active's potential side effects can be summarized as follows: niacinamide is generally well tolerated; above 10% it can cause redness and occasionally a temporary warm sensation. Kojic acid carries a contact dermatitis risk above 2%. AHA (glycolic acid) causes burning, flaking, and irritation when applied to a weakened barrier. Azelaic acid at 20% can cause mild initial burning that usually resolves within 2–3 weeks. Retinol can initially cause purging (a temporary increase in breakouts), dryness, and flaking. Topical tranexamic acid is generally safe; the systemic form should only be used under physician supervision. Combining all of these actives with a barrier-supporting moisturizer meaningfully lowers the side-effect profile.
When should you see a dermatologist for PIH or PIE?
A dermatologist evaluation is needed in the following situations: no noticeable improvement after 3–4 months of consistent at-home care; marks appear gray-blue rather than superficial, suggesting dermal PIH; PIH is occurring alongside hormonal melasma related to pregnancy or PCOS; recurring irritation or allergic reaction to active treatment ingredients; severe nodulocystic acne present alongside the marks; or concurrent conditions like rosacea or atopic dermatitis complicating PIH/PIE management. Strong interventions like hydroquinone, tretinoin, and chemical peels should always be used under dermatological supervision.
In what order should actives be applied in a PIH/PIE skincare routine?
The correct application order directly affects effectiveness. Morning routine: 1) pH-balanced gentle cleanser → 2) antioxidant serum (optional, containing vitamin C or niacinamide) → 3) ceramide-containing moisturizer → 4) SPF 30–50 (always the final layer). Night routine: 1) pH-balanced cleanser → 2) active serum (niacinamide / tranexamic acid / azelaic acid) → 3) retinol (2–3 nights a week, skip on other nights) → 4) ceramide moisturizer. AHA peels are used at night, 1–2 times a week, and shouldn't be scheduled on the same night as retinol. Sunscreen is always the final step of the morning routine; reapplying over makeup isn't required for protection the following day.
Are PIH and hyperpigmentation the same thing?
No — hyperpigmentation is a broad umbrella term, while PIH specifically refers to hyperpigmentation that develops after inflammation. Categories under the hyperpigmentation umbrella include: PIH (post-inflammatory — from acne, eczema, insect bites), melasma (hormonal, UV-triggered, larger areas), solar lentigo (age spots, cumulative UV exposure), ephelides (freckles, genetic-UV related), and drug-induced hyperpigmentation. Melasma and PIH are frequently confused; melasma is usually symmetric, hormone-dependent, and covers larger areas, while PIH is localized to acne lesion sites. Tranexamic acid is one of the rare actives effective against both.
How long do PIH and PIE take to fade, and when will I see results?
Epidermal PIH can noticeably lighten within an average of 3–6 months with the right protocol (niacinamide + AHA + SPF). Dermal PIH responds much more slowly and can take 1–2 years or longer; in some cases, complete resolution may not be possible. PIE typically improves within 3–12 months once vascular repair is supported (azelaic acid + centella + barrier care) — this timeline can be shorter in fair-skinned individuals. The earliest observable effect from any active ingredient comes after at least 4–8 weeks of consistent use; changing your protocol out of impatience only prolongs the process. Every day without sun protection directly extends treatment time.
References
- Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol, 2010.
- Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol, 2002.
- Arif T. Salicylic acid as a peeling agent: a comprehensive review. Clin Cosmet Investig Dermatol, 2015.
Further Reading
CIRÈLL Barrier Repair Cream
The scientific skin barrier principles discussed in this article form the foundation of the CIRÈLL Biomimetic Tribarrier Cream formulation.
View the Product